April 10, 2024 8:38am

Will it provide a stumbling block to “our” universe’s share pricing - again?

Subscription is coming; a “buck” a day will keep your portfolio in play - be a subscriber to continue reading! Join me … in the NO spin zone and new website!

A string of reports showing inflation and the economy have remained hotter than expected has forced the “Street” to delay forecasts for when relief on rates could arrive

Never leave an investor uninformed!

Remember that overnight and pre-open actions’ futures and global markets doesn't necessarily translate into actual trading in the today’s market session.

Framing the main takeaway … pricing, volume and volatility!

My version of the morning’s numbers is written to be informative; it’s including what happened or will beyond the headline and shapes today’s potential sector response as seen by RMi.

 

Wednesday: The pre-open Dow futures are DOWN -0.86% or (-339 points), the S&P futures are DOWN -0.97% or (-49 points) as the Nasdaq futures are DOWN -1.17% or (-216 points)

Stock futures dived on Wednesday, April 10, 2024,

European stocks were higher,

Asia markets mostly fall as Japan corporate inflation climbs.

 

Henry’omics:

We need to more than consider the economic environment to comprehend the micro re “our” universe of cell and gene therapy companies …

Tuesday: The Dow closed DOWN -9.13 points or -0.02%, the S&P closed UP +7.52 points or +0.14% while the Nasdaq closed UP +52.68 points or +0.32%

Traders are looking to the CPI data for clues on how central bank policymakers may proceed on interest rates — and the outcome is sure to affect today’s market moves.

Economic Data Docket:Consumer prices rose 3.5% from a year ago in March, more than expected …

  • The consumer price index increased at a faster than expected pace in March, indicating that inflation is staying stubbornly higher and likely keeping the Fed on hold with interest rates.
  • The CPI, a broad measure of goods and services costs across the economy, rose 0.4% for the month, putting the 12-month inflation rate at 3.5%. Economists had been looking for a 0.3% gain and a 3.4% year-over-year level.

investos are also looking forward to the meeting minutes (at 2 p.m.) from the Fed’s gathering last month. They will be hunting for clues on where policymakers stand on expected rate cuts this year.

 

Tuesday’s night RegMed Investors (RMi) Closing Bell: I am sick and tired of those analysts spouting long term price targets beyond the realm and comprehension of share pricing.” … https://www.regmedinvestors.com/articles/13410

 

Q2/24:  April - 5 negative and 2 positive closes

Q1/24:

  • March – 8 positive and 12 negative closes
  • February – 1 market holiday, 11 positive and 9 negative closes
  • January: 2 holidays, 11 negative and 8 positive closes

 

Companies in my headlights – It’s your decision; I provide ideas and context:

I post about “indication intelligence” devoting my time to collection and analysis of information to assist investors with insight into sector vulnerabilities and strengths. A dictionary definition of “indicate” refers to something less than a certainty; an indication could be a signal of being oversold or overbought, a recommendation, or grounds for inferring or a basis for believing.

 

Yet again, I am passing on forecasting the daily indications is focused on inflation-oriented CPI report “numbers” the aftermarket fluctuated as the pre-open waits for the all-clear alarm, …  it is still a mix of ups, downs and just unknowns.

 

The BOTTOM LINE: indexes had a usual session/day (the Dow split to the downside as the S&P and Nasdaq pooped upward), and cell and gene therapy sector winners (20) outpaced losers (12) of my covered 35.

  • Wait and watch which way the major indexes and sector equities break.

Key word of the state of uncertainty in “our” universe of cell and gene therapy … “which makes It difficult to predict where sector is headed in the short run.”

  • I STILL believe the political aspect of the country’s polarization, and disparities of the debt ceilings and rate hike arguments are contributing to the roller coaster ride for share pricing actions
  • Investors should still be cautious in the current downslide sector, yet I still see some oversold equities especially with today's jobs report on the horizon.

Never forget, one of my usual lines. “The sector is … still what it is, until it isn’t and even then, it doesn’t seem to be … that is after taking a deep breath and holding it.”

  • I am more frequently right than consequentially wrong; if I wanted to be liked, I wouldn’t have been an analyst/journalist.

Welcome to my world of defining the “grey’ in our universe!

  • Right up front, “I also hate to be so negative or contrarian but, this is a NO spin zone and facts are its product; I can always be WRONG but … I am mostly EARLY!”
  • The sector is what it is, until it isn’t and even then, it doesn’t seem to be… as NOT much changes as the sector’s share pricing rides the waves of volatility, algorithms, electronic trading and short covering.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. All investments are subject to risks. Investors should consider investment objectives.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.  Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.

Henry McCusker, the editor and publisher of RegMed Investors could hold or have positions securities referred to in this publication and he will NOTIFY investors of holdings.